Skip to main content

Table 2 Univariate analysis of clinical parameters observed in connection with the baseline FDG-PET that were associatied with overall survival

From: Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma

 

HR (95% CI)

The hottest lesion: high SUVmaxa

3.56(1.63-7.76)*

The hottest lesion: high SULpeaka

2.67(1.22-5.84)*

The hottest lesion: high TLG50a

2.45(1.14-5.27)*

The hottest lesion: high TLG2.5a

1.74(0.83-3.63)

Rating of Heng factor: 1 versus 2 and 3

0.33(0.11-0.96)*

ECOG performance status: 0 versus 1 and 2

1.94(0.91-4.14)

Pretreatment: yes versus none

1.57(0.75-3.27)

  1. aComparing above and below median value.
  2. * = Statiscially significant.